IL1B and necrotizing enterocolitis: The only study to date reporting on the effect of adipose tissue in the setting of necrotizing enterocolitis was conducted by Mimatsu et al. [46], who showed that the administration of differentiated fat cells, and not adipose-derived stem cells, improved survival rates and facilitated the repair of damaged intestinal tissues in NEC, potentially through normalizing the expression of fatty acid-related proteins, reducing inflammation, and lowering the levels of IL-1 and IL-6 [46].